News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

Peter Hölig, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany

Correspondence: Lipoid GmbH, Frigenstraße 4, D-67065 Ludwigshafen, Germany, Tel: +49 621 53819 301, [email protected]

Articles by Peter Hölig, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany

Phospholipids in Pharmaceutical Form Line Extensions

ByPeter Hölig, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany,Peter van Hoogevest, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany

October 1st 2022

Pharma Insights - Thought Leadership from Marketers | Paid Program

Synthetic Phospholipids as Excipients for Parenteral and Pulmonary Administration

ByPeter van Hoogevest, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany,Peter Hölig, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany

September 22nd 2021

Pharma Insights - Thought Leadership from Marketers | Paid Program

Latest Updated Articles

Trending on Pharmaceutical Technology

GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push

Why Big Pharma Is Betting Billions on Protein Degraders for Cancer

Patient Access to Radiopharmaceuticals

USP Reports Drug Discontinuations on the Rise

EMA Approved 104 Human Medicines in 2025